JUN and metabolic dysfunction-associated steatotic liver disease: In the nonalcoholic fatty liver disease-associated hepatocellular carcinoma model, increased palmitic acid enhanced the protein expression of endoplasmic reticulum-activating oncogenic JNK/c-jun/AP-1 and NF-κB cascades (42).